Page last updated: 2024-08-25

zoledronic acid and Inflammation

zoledronic acid has been researched along with Inflammation in 39 studies

Research

Studies (39)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (5.13)	29.6817
2010's	27 (69.23)	24.3611
2020's	10 (25.64)	2.80

Authors

Authors	Studies
Bhansali, A; Das, L; Dutta, P; Jude, EB; Prakash, M; Rastogi, A	1
Azetsu, Y; Chatani, M; Ikeda, M; Karakawa, A; Sakai, N; Suzuki, N; Takami, M; Takizawa, H	1
Heitzer, M; Hölzle, F; Kniha, K; Modabber, A; Möhlhenrich, SC; Peters, F; Rink, L; Wolf, J	1
Chen, L; Fu, X; Jiang, J; Yang, J; Yang, Z; Yu, C; Yu, X	1
Chen, M; Huang, M; Jiao, Y; Pan, J; Sun, Z; Wang, S; Ye, G; Ye, W; Zhang, D; Zhao, J	1
Albuquerque, MCP; Alves, APNN; Borges, MMF; Carlos, ACAM; Dantas, TS; Lemos, JVM; Silva, PGB; Sousa, FB	1
Han, LS; Weatherhead, RG	1
Du, Y; Kong, F; Li, J; She, P; Yao, C; Zhang, F; Zhang, Q	1
Khalid, MF; Micieli, J	1
Ferchak, MA; Greenspan, SL; Langmann, GA; Nace, DA; Perera, S; Resnick, NM	1
Bank, I; Loebstein, R; Markovits, N	1
Alves, APNN; Brizeno, LAC; de Barros Silva, PG; de Oliveira, CC; Ferreira Junior, AEC; Lima Júnior, RCP; Mota, MRL; Sousa, FB; Wong, DVT	1
Herren, D; Kim, SJ; Kohanim, S; Umunakwe, OC	1
Açil, Y; Arndt, ML; Ayna, M; Gülses, A; Naujokat, H; Wieker, H; Wiltfang, J	1
Agamennone, M; Campestre, C; Cataldi, A; De Colli, M; Loiodice, F; Tortorella, P; Zara, S	1
Kalin-Hajdu, E; Martin, TG; Narayan, R; Tan, M; Wong, SW	1
Benfica, JRD; Etges, A; Langie, R; Munaretto, JC; Pacheco, VN; Ponzoni, D; Puricelli, E	1
Chehade, LK; Curragh, D; Selva, D	1
Bando, K; Endo, Y; Funayama, H; Kiyama, T; Oizumi, T; Sugawara, S; Suzuki, H; Tada, H; Takahashi, T	1
Bafaloukos, D; Karagianni, A; Linardou, H; Michalakakou, K; Nicolatou-Galitis, O; Papadopoulou, E; Papassotiriou, I; Tarampikou, A; Tsixlakis, K; Vardas, E	1
Ebbinghaus, M; Eitner, A; Hess, A; Hilger, I; Kamradt, T; Müller, S; Schaible, HG; Segond von Banchet, G; Wank, I	1
Kaltsa, A; Karga, H; Ktena, V; Mavropoulos, J; Papaioannou, G; Papandroulaki, F; Pardalakis, A; Sykiotis, A; Thanou, S; Triantaphyllopoulou, M	1
Matsumoto, A; Muratsu, D; Nakamura, S; Onimura, T; Seki, Y; Taketomi, T; Yoshiga, D	1
Allen, MR; Chen, NX; Gattone, VH; Moe, SM	1
Bodman-Smith, MD; Copier, J; Dalgleish, AG; Fowler, DW	1
Badens, C; Bonello-Palot, N; Bourgeois, P; Dignat-George, F; Levy, N; Robert, S; Sabatier, F; Simoncini, S	1
Askmyr, M; Baker, EK; Ebeling, PR; Harrison, SJ; Jovic, T; Neeson, P; Purton, LE; Quach, JM; Ritchie, D; Walsh, NC	1
Anitua, E; Orive, G; Troya, M; Zalduendo, M	1
Aras, MH; Bozdag, Z; Cetiner, S; Demir, T; Keskinruzgar, A; Yolcu, U	1
Agamennone, M; Campestre, C; Cataldi, A; De Colli, M; Marconi, GD; Tauro, M; Tortorella, P; Zara, S	1
Eufinger, H; Hoefert, S; Schmitz, I; Tannapfel, A	1
Cankaya, M; Ersoz, S; Gunhan, O; Kadioglu Duman, M; Muci, E; Pampu, AA; Senel, FC	1
Adams, JS; Christensen, R; Chung, EM; Felsenfeld, AL; Garrett, N; Hokugo, A; Nishimura, I; Sayre, JW; Sung, EC	1
Missotten, G; Verheezen, Y	1
Corretger, X; Fernandez, E; Molina, JJ; Navarro, M; Olver, JM; Ortiz-Perez, S; Sanchez-Dalmau, B	1
Atik, OS	1
Hirai, M; Kadowaki, N; Kitawaki, T	1
Stiff, PJ; Tanvetyanon, T	1
Berger, SA; Bogoch, ER; Fornasier, VL; Lee, TC	1

Reviews

3 review(s) available for zoledronic acid and Inflammation

Article	Year
Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature. Digital journal of ophthalmology : DJO, 2017, Volume: 23, Issue:4 Topics: Acute Disease; Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Inflammation; Infusions, Intravenous; Orbital Diseases; Osteoporosis; Tomography, X-Ray Computed; Uveitis, Anterior; Zoledronic Acid	2017
[Therapy for malignancies and inflammatory disorders by modulating human dendritic cell functions]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2011, Volume: 52, Issue:7 Topics: Cancer Vaccines; Cell- and Tissue-Based Therapy; Cells, Cultured; Dendritic Cells; Diphosphonates; Humans; Imidazoles; Immunotherapy; Inflammation; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Neoplasms; WT1 Proteins; Zoledronic Acid	2011
Management of the adverse effects associated with intravenous bisphosphonates. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:6 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Inflammation; Infusions, Intravenous; Osteoclasts; Pamidronate; Zoledronic Acid	2006

Trials

3 trial(s) available for zoledronic acid and Inflammation

Article	Year
Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus. PloS one, 2021, Volume: 16, Issue:11 Topics: Anti-Inflammatory Agents; Arthropathy, Neurogenic; Bone Density; Bone Density Conservation Agents; Diabetes Mellitus, Type 2; Diabetic Foot; Diabetic Neuropathies; Female; Humans; Inflammation; Male; Methylprednisolone; Middle Aged; Osteogenesis; Treatment Outcome; Zoledronic Acid	2021
Nitrogen-containing bisphosphonate therapy-Part II: Assessment of alveolar bone tissue inflammatory response in rats-A blind randomized controlled trial. International journal of experimental pathology, 2018, Volume: 99, Issue:5 Topics: Alveolar Process; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Remodeling; Diphosphonates; Disease Models, Animal; Inflammation; Male; Nitrogen; Osteonecrosis; Rats; Rats, Wistar; Tomography, X-Ray Computed; Zoledronic Acid	2018
Markers of inflammation after zoledronic acid redosing. Journal of bone and mineral metabolism, 2014, Volume: 32, Issue:1 Topics: Biomarkers; Bone Density Conservation Agents; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Inflammation; Middle Aged; Osteoporosis, Postmenopausal; Regression Analysis; Zoledronic Acid	2014

Other Studies

33 other study(ies) available for zoledronic acid and Inflammation

Article	Year
Effects of Anti-Receptor Activator of Nuclear Factor Kappa B Ligand Antibody and Zoledronic Acid on Periapical Lesion Development in Mice. Journal of endodontics, 2022, Volume: 48, Issue:5 Topics: Animals; Bone Density Conservation Agents; Bone Resorption; Inflammation; Mice; NF-kappa B; Osteoclasts; RANK Ligand; Zoledronic Acid	2022
Host inflammatory response and clinical parameters around implants in a rat model using systemic alendronate and zoledronate acid drug administrations. Scientific reports, 2022, 03-15, Volume: 12, Issue:1 Topics: Alendronate; Animals; Dental Implants; Inflammation; Interleukin-6; Metal Nanoparticles; Osseointegration; Rats; Rats, Sprague-Dawley; Titanium; Tumor Necrosis Factor-alpha; Zirconium; Zoledronic Acid	2022
Small molecule-assisted assembly of multifunctional ceria nanozymes for synergistic treatment of atherosclerosis. Nature communications, 2022, 11-01, Volume: 13, Issue:1 Topics: Atherosclerosis; Humans; Inflammation; Nanoparticles; Reactive Oxygen Species; Zoledronic Acid	2022
Zoledronic acid and thymosin α1 elicit antitumor immunity against prostate cancer by enhancing tumor inflammation and cytotoxic T cells. Journal for immunotherapy of cancer, 2023, Volume: 11, Issue:6 Topics: Androgen Antagonists; Androgens; Animals; CD8-Positive T-Lymphocytes; Humans; Inflammation; Male; Mice; Prostatic Neoplasms; Retrospective Studies; T-Lymphocytes, Cytotoxic; Thymalfasin; Tumor Microenvironment; Zoledronic Acid	2023
Interleukin-17 plays a role in dental pulp inflammation mediated by zoledronic acid: a mechanism unrelated to the Th17 immune response? Journal of applied oral science : revista FOB, 2023, Volume: 31 Topics: Animals; Dental Pulp; Digoxin; Immunity; Inflammation; Interleukin-17; Interleukin-6; Male; Rats; Rats, Wistar; Saline Solution; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Zoledronic Acid	2023
Zoledronic acid associated orbital inflammation. Clinical & experimental ophthalmology, 2020, Volume: 48, Issue:2 Topics: Bone Density Conservation Agents; Female; Glucocorticoids; Humans; Inflammation; Methylprednisolone; Middle Aged; Orbital Diseases; Osteoporosis, Postmenopausal; Tomography, X-Ray Computed; Zoledronic Acid	2020
Implantable zoledronate-PLGA microcapsules ameliorate alveolar bone loss, gingival inflammation and oxidative stress in an experimental periodontitis rat model. Journal of biomaterials applications, 2021, Volume: 35, Issue:6 Topics: Alveolar Bone Loss; Animals; Antioxidants; Capsules; Catalase; Cytokines; Disease Models, Animal; Gingiva; Humans; Inflammation; Osteoprotegerin; Oxidative Stress; Polylactic Acid-Polyglycolic Acid Copolymer; Prosthesis Implantation; Rats; Superoxide Dismutase; Zoledronic Acid	2021
Zoledronic acid-induced orbital inflammation. BMJ case reports, 2021, Aug-19, Volume: 14, Issue:8 Topics: Bone Density Conservation Agents; Diphosphonates; Eye Diseases; Humans; Inflammation; Neurology; Zoledronic Acid	2021
Inflammatory Markers and Frailty in Long-Term Care Residents. Journal of the American Geriatrics Society, 2017, Volume: 65, Issue:8 Topics: Activities of Daily Living; Aged; Biomarkers; Bone Density Conservation Agents; Cytokines; Diphosphonates; Female; Frail Elderly; Humans; Imidazoles; Inflammation; Long-Term Care; Osteoporosis; Zoledronic Acid	2017
Immune-mediated syndromes following intravenous bisphosphonate therapy. Inflammopharmacology, 2017, Volume: 25, Issue:6 Topics: Aged; Arthritis, Rheumatoid; Autoimmune Diseases; Crohn Disease; Diphosphonates; Female; Humans; Imidazoles; Inflammation; Infusions, Intravenous; Male; Polymyalgia Rheumatica; Retrospective Studies; Syndrome; Zoledronic Acid	2017
Chronic treatment with zoledronic acid increases inflammatory markers in periodontium of rats. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2017, Volume: 46, Issue:10 Topics: Animals; Biomarkers; Bone Density Conservation Agents; Diphosphonates; Imidazoles; Inflammation; Male; Oxidative Stress; Periodontium; Rats; Rats, Wistar; Zoledronic Acid	2017
Cytotoxic and inflammatory effects of alendronate and zolendronate on human osteoblasts, gingival fibroblasts and osteosarcoma cells. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2018, Volume: 46, Issue:4 Topics: Alendronate; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytokines; Cytotoxins; Diphosphonates; Dose-Response Relationship, Drug; Fibroblasts; Gene Expression; Gingiva; Humans; Imidazoles; Inflammation; Osteoblasts; Osteosarcoma; Real-Time Polymerase Chain Reaction; Zoledronic Acid	2018
Bisphosfonate matrix metalloproteinase inhibitors for the treatment of periodontitis: An in vitro study. International journal of molecular medicine, 2018, Volume: 42, Issue:1 Topics: Cell Death; Cell Membrane; Collagen Type I; Culture Media; Diphosphonates; Fibroblasts; Gingiva; Humans; Imidazoles; Inflammation; Lipopolysaccharides; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Periodontitis; Zoledronic Acid	2018
Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:5 Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Inflammation; Male; Middle Aged; Multiple Myeloma; Orbital Diseases; Zoledronic Acid	2019
Bisphosphonate-induced orbital inflammation: more common than once thought? Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2019, Volume: 30, Issue:5 Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Inflammation; Magnetic Resonance Imaging; Middle Aged; Orbital Diseases; Risedronic Acid; Tomography, X-Ray Computed; Zoledronic Acid	2019
Augmentation of Lipopolysaccharide-Induced Production of IL-1α and IL-1β in Mice Given Intravenous Zoledronate (a Nitrogen-Containing Bisphosphonate) and Its Prevention by Clodronate (a Non-nitrogen-containing Bisphosphonate). Biological & pharmaceutical bulletin, 2019, Volume: 42, Issue:2 Topics: Animals; Bone Density Conservation Agents; Clodronic Acid; Drug Synergism; Inflammation; Interleukin-1beta; Lipopolysaccharides; Liver; Male; Mice; Pectoralis Muscles; Spleen; Zoledronic Acid	2019
The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and/or bevacizumab. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020, Volume: 28, Issue:1 Topics: Aged; Aged, 80 and over; Bevacizumab; Biomarkers; Drug Therapy, Combination; Female; Gingival Crevicular Fluid; Humans; Inflammation; Interleukin-17; Male; Middle Aged; Neoplasms; Neovascularization, Pathologic; Osteonecrosis; Periodontal Diseases; Periodontal Pocket; Predictive Value of Tests; Vascular Endothelial Growth Factor A; Zoledronic Acid	2020
Contribution of Inflammation and Bone Destruction to Pain in Arthritis: A Study in Murine Glucose-6-Phosphate Isomerase-Induced Arthritis. Arthritis & rheumatology (Hoboken, N.J.), 2019, Volume: 71, Issue:12 Topics: Activating Transcription Factor 3; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Bone Resorption; Cyclic AMP Response Element-Binding Protein; Glucose-6-Phosphate Isomerase; Hindlimb; Hyperalgesia; Inflammation; Mice; Pain; T-Lymphocytes, Regulatory; TRPV Cation Channels; Zoledronic Acid	2019
Zoledronic acid enhances lipopolysaccharide-stimulated proinflammatory reactions through controlled expression of SOCS1 in macrophages. PloS one, 2013, Volume: 8, Issue:7 Topics: Animals; Apoptosis; Cell Line; Cytokines; Diphosphonates; Gene Expression Regulation; Imidazoles; Immunity, Innate; Inflammation; Lipopolysaccharides; Macrophage Activation; Macrophages; Mice; Myeloid Differentiation Factor 88; NF-kappa B; Nitric Oxide; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling Proteins; Toll-Like Receptor 4; Zoledronic Acid	2013
Adverse mandibular bone effects associated with kidney disease are only partially corrected with bisphosphonate and/or calcium treatment. American journal of nephrology, 2013, Volume: 38, Issue:6 Topics: Animals; Bone Diseases; C-Reactive Protein; Calcium; Dental Cementum; Dental Enamel; Diphosphonates; Disease Models, Animal; Heterozygote; Imidazoles; Inflammation; Kidney Diseases; Male; Mandible; Parathyroid Hormone; Periodontitis; Phenotype; Rats; Tomography, X-Ray Computed; X-Ray Microtomography; Zoledronic Acid	2013
Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homing. Immunology, 2014, Volume: 143, Issue:4 Topics: Apoptosis; Cell Degranulation; Cell Line; Cell Movement; Diphosphonates; Humans; Imidazoles; Immunomodulation; Inflammation; Leukocytes, Mononuclear; Monocytes; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Zoledronic Acid	2014
Prelamin A accumulation in endothelial cells induces premature senescence and functional impairment. Atherosclerosis, 2014, Volume: 237, Issue:1 Topics: Atazanavir Sulfate; Cell Adhesion; Cell Proliferation; Cells, Cultured; Cellular Senescence; Diphosphonates; Endothelial Cells; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Inflammation; Intercellular Adhesion Molecule-1; Lamin Type A; Microscopy, Fluorescence; Monocytes; Neovascularization, Pathologic; Nuclear Proteins; Oligopeptides; Pravastatin; Progeria; Protein Precursors; Pyridines; Umbilical Cord; Umbilical Veins; Zoledronic Acid	2014
Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone loss. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2015, Volume: 30, Issue:5 Topics: Animals; Antineoplastic Agents; Bone Density; Bone Remodeling; Bone Resorption; Chemokine CCL2; Cytokines; Diphosphonates; Hematopoiesis; Imidazoles; Inflammation; Inflammation Mediators; Mice, Inbred C57BL; Stem Cell Transplantation; Transplantation, Homologous; X-Ray Microtomography; Zoledronic Acid	2015
PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells. Clinical oral investigations, 2016, Volume: 20, Issue:3 Topics: Alveolar Process; Apoptosis; Blotting, Western; Bone Density Conservation Agents; Cell Proliferation; Diphosphonates; Fibroblasts; Gingiva; Humans; Imidazoles; In Vitro Techniques; Inflammation; Intercellular Signaling Peptides and Proteins; NF-kappa B; Osteoblasts; Plasma; Zoledronic Acid	2016
Histopathological Effects of Teriparatide in Medication-Related Osteonecrosis of the Jaw: An Animal Study. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2016, Volume: 74, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cell Count; Dexamethasone; Diphosphonates; Disease Models, Animal; Imidazoles; Inflammation; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Molar; Osteoblasts; Osteoclasts; Rats; Rats, Wistar; Teriparatide; Tooth Extraction; Wound Healing; Zoledronic Acid	2016
In vitro comparison of new bisphosphonic acids and zoledronate effects on human gingival fibroblasts viability, inflammation and matrix turnover. Clinical oral investigations, 2016, Volume: 20, Issue:8 Topics: Adult; Biomarkers; Blotting, Western; Bone Density Conservation Agents; Cell Adhesion; Cell Survival; Diphosphonates; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Gingiva; Humans; Imidazoles; In Vitro Techniques; Inflammation; Molar, Third; Zoledronic Acid	2016
Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. Clinical oral investigations, 2010, Volume: 14, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Connective Tissue; Diphosphonates; Female; Humans; Imidazoles; Inflammation; Jaw; Jaw Diseases; Male; Mandibular Diseases; Maxillary Diseases; Microscopy, Electron, Scanning; Middle Aged; Osteomyelitis; Osteonecrosis; Osteoporosis; Osteoradionecrosis; Pamidronate; Time Factors; Zoledronic Acid	2010
Jaw bone changes in rats after treatment with zoledronate and pamidronate. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2010, Volume: 109, Issue:3 Topics: Animals; Bone Density Conservation Agents; Diphosphonates; Disease Models, Animal; Female; Femur; Imidazoles; Inflammation; Mandible; Osteonecrosis; Pamidronate; Rats; Rats, Sprague-Dawley; Single-Blind Method; Time Factors; Zoledronic Acid	2010
Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2010, Volume: 25, Issue:6 Topics: Animals; Apoptosis; Diphosphonates; Disease Models, Animal; Femur; Gene Expression Regulation; Humans; Imidazoles; Inflammation; Jaw Diseases; Oligonucleotide Array Sequence Analysis; Osteoclasts; Osteogenesis; Osteonecrosis; Rats; Rats, Sprague-Dawley; Tooth Extraction; Vitamin D; Vitamin D Deficiency; Zoledronic Acid	2010
Orbital inflammation after use of zoledronic acid for metastasized prostate carcinoma. Bulletin de la Societe belge d'ophtalmologie, 2010, Issue:315 Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Conjunctivitis, Acute Hemorrhagic; Diphosphonates; Humans; Imidazoles; Inflammation; Male; Neoplasms, Second Primary; Neurofibroma; Orbital Diseases; Orbital Neoplasms; Prostatic Neoplasms; Zoledronic Acid	2010
Two cases of drug-induced orbital inflammatory disease. Orbit (Amsterdam, Netherlands), 2011, Volume: 30, Issue:1 Topics: Aged; Bone Density Conservation Agents; Cataract Extraction; Cellulitis; Diagnosis, Differential; Diphosphonates; Female; Humans; Hyaluronoglucosaminidase; Imidazoles; Inflammation; Orbital Diseases; Paget Disease, Extramammary; Zoledronic Acid	2011
What do we know about the ocular adverse effects associated with intravenous bisphosphonates? Eklem hastaliklari ve cerrahisi = Joint diseases & related surgery, 2011, Volume: 22, Issue:1 Topics: Bone Density Conservation Agents; Diphosphonates; Eye Diseases; Humans; Imidazoles; Inflammation; Infusions, Intravenous; Osteoporosis, Postmenopausal; Zoledronic Acid	2011
Articular damage is associated with intraosseous inflammation in the subchondral bone marrow of joints affected by experimental inflammatory arthritis and is modified by zoledronate treatment. The Journal of rheumatology, 2007, Volume: 34, Issue:6 Topics: Animals; Arthritis, Experimental; Bone Density Conservation Agents; Bone Marrow; Bone Marrow Diseases; Carrageenan; CD11b Antigen; CD3 Complex; CD4 Antigens; Diphosphonates; Disease Models, Animal; Female; Imidazoles; Inflammation; Joints; Rabbits; Rats; Rats, Sprague-Dawley; Spleen; Zoledronic Acid	2007